After 3 exceptionally successful diabetic foot ulcer treatment pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with D’OXYVA®
After three exceptionally successful diabetic foot ulcer pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with its D’OXYVA® (deoxyhemoglobin vasodilator)